Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Nurofen Joint & Muscular Pain Relief 200mg plasters
1003020P0BLAEAK
|
Nurofen (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | 7 |
|
Nurofen Joint & Back Pain Relief Max Strength 10% gel
1003020P0BLACAI
|
Nurofen (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | 2 |
|
Nurofen 5% gel
1003020P0BLAAAC
|
Nurofen (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Joint & Back Pain Relief 5% gel
1003020P0BLADAC
|
Nurofen (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
|
Nurofen Maximum Strength 10% gel
1003020P0BLABAI
|
Nurofen (Topical) | Ibuprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.